as on February 18, 2026 at 7:59 am IST
Day's Low
Day's High
2.95%
Downside
4.00%
Upside
52 Week's Low
52 Week's High
3.93%
Downside
348.56%
Upside
Check Hims & Hers Health Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.7B
EPS (TTM)
0.4725
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.80%
PE Ratio (TTM)
30.75
Industry PE ratio
4.741428571428571
PEG Ratio
0.9156
EBITDA
168.1M
Revenue (TTM)
2.2B
Profit Margin
6.05%
Return On Equity TTM
26.21%
Track how Hims & Hers Health Inc P/E has moved over time to understand its valuation trends.
Hims & Hers Health Inc in the last 5 years
Lowest (-67.20x)
December 31, 2023
Industry (4.74x)
February 17, 2026
Today (30.75x)
February 17, 2026
Highest (99.61x)
December 31, 2025
Today’s Price to Earnings Ratio: 30.75x
Compare market cap, revenue, PE, and other key metrics of Hims & Hers Health Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.7B | -22.53% | 30.75 | 6.05% | |
| NA | $15.4B | NA | NA | 0.00% | |
| BUY | $21.4B | NA | 17.96 | 40.65% | |
| BUY | $49.9B | NA | 24.89 | 13.81% | |
| HOLD | $18.2B | -14.85% | -21.95 | -26.13% |
The Hims & Hers Health Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Hims & Hers Health Inc investment value today
Current value as on today
₹31,300
Returns
Returns from Hims & Hers Health Inc Stock
Dollar Returns*
₹4,394 (+4.39%)
Based on 19 analysts
68.42%
Buy
31.58%
Hold
0.00%
Sell
Based on 19 analysts, 68.42% of analysts recommend a 'BUY' rating for Hims & Hers Health Inc. Average target price of $29.96
Get share price movements and forecasts by analysts on Hims & Hers Health Inc.
What analysts predicted
45.69%UPSIDE
Target Price
$29.96
Current Price
$16.27
Analyzed by
19 Analysts
Target
$29.96
Hims & Hers Health Inc target price $29.96, a slight upside of 45.69% compared to current price of $16.27. According to 19 analysts rating.
Investment in Hims & Hers Health Inc Shares on INDmoney has grown by 55.74% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:55.74% versus previous 30 day period
Search interest for Hims & Hers Health Inc Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:32% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 10 February
Tue, 11:46 AM
-Hims stock dropped about 20% amid criticism of a lawsuit targeting patient access to compounded medications.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 544.83M → 598.97M (in $), with an average increase of 9.0% per quarter
Against Peers
![]()
In the last 1 year, Regencell Bioscience Holdings Ltd has given 31953.4% return, outperforming this stock by 32025.5%
Against Peers
![]()
In the last 3 years, Regencell Bioscience Holdings Ltd has given 4286.1% return, outperforming this stock by 4216.8%
Profit Down
![]()
Netprofit is down for the last 3 quarters, 49.48M → 15.77M (in $), with an average decrease of 38.5% per quarter
Price Dip
![]()
In the last 1 month, HIMS stock has moved down by -48.1%
| Organisation | Hims & Hers Health Inc |
| Headquarters | 2269 Chestnut Street, San Francisco, CA, United States, 94123 |
| Industry | Healthcare |
| CEO | Mr. Andrew Dudum |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Peter Stahl M.D. | Senior Vice President of Men's Reproductive & Sexual Health |
Mr. Oluyemi Okupe | Chief Financial Officer |
Mr. Mike Chi | Chief Operating Officer |
Dr. Patrick Carroll M.D. | Chief Medical Officer & Director |
Ms. Irene A. Becklund | Senior VP, Controller & Principal Accounting Officer |
Mr. Mohamed ElShenawy | Chief Technology Officer |
Mr. Andrew Dudum | Co-Founder, Chairman & CEO |
Ms. Soleil Teubner Boughton J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Deborah M. Autor J.D. | Chief Policy Officer & Director |
Dr. Daniel Lieberman M.D. | Senior Vice President of Mental Health |
Hims & Hers Health Inc share price today is $16.27 as on at the close of the market. Hims & Hers Health Inc share today touched a day high of $16.92 and a low of $15.79.
Hims & Hers Health Inc share touched a 52 week high of $72.98 on and a 52 week low of $15.63 on . Hims & Hers Health Inc stock price today i.e. is closed at $16.27,which is 77.71% down from its 52 week high and 4.09% up from its 52 week low.
Hims & Hers Health Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Hims & Hers Health Inc (HIMS) shares with as little as ₹90.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.52 in Hims & Hers Health Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Hims & Hers Health Inc share’s latest price of $16.27 as on February 18, 2026 at 2:29 am IST, you will get 0.6146 shares of Hims & Hers Health Inc. Learn more about
fractional shares .
Hims & Hers Health Inc stock has given -22.53% share price returns and 24.64% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?